Stately Bio

Stately Bio is a startup that develops cell therapies using an ML-driven live cell imaging platform. Established in 2022 and headquartered in Palo Alto, Stately Bio has developed an industry-leading computational platform that provides rapid, real-time insights into cell identity, quality, and behavior based on live cell imaging. Stately Bio is leveraging the technological advantages of its platform to develop cell therapies and regenerative medicines for diseases with unmet treatment needs.